Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AusCann.
RELATED STOCKHEAD STORIES
News
Weed Week: American pot could be worth $60 billion by 2025
News
Weed week: cannabis is about to get scary in Canada
Food & Agriculture
Pot: Better late than never … AusCann seals supply deal from 2 years ago
Health & Biotech
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Cannabis: Cann is Australia’s pot king after scoring a manufacturing licence through IDT
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
Food & Agriculture
Cannabis: THC is allowed to export, but still no sign of one crucial licence
Health & Biotech
The Pot Seat: AusCann’s Mal Washer says today they’re pharma, not a farmer
Food & Agriculture
Weed Week: How do you compete in the US? Money and Martha Stewart
Health & Biotech
Check-up: What’s happening with the ASX small cap health stocks?
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
AusCann snags a new CEO from Israel – and he’ll get 35pc more than the outgoing female boss
Health & Biotech
The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs
Health & Biotech
